Search Results for " Zanubrutinib "
Zanubrutinib Related Products
Zanubrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor, which is a class of drugs that targets a protein involved in the development and function of certain immune cells. Zanubrutinib is primarily used for the treatment of certain types of blood cancers.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Zanubrutinib, pharmacopeial and non-pharmacopeial Zanubrutinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Zanubrutinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Zanubrutinib-related products are thoroughly characterized. Zanubrutinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.